10,375.00
-300.00
(-2.81%)
At close: January 10 at 4:57:21 PM GMT-3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 8 | 30 | 29 |
| Avg. Estimate | 8.86B | 8.17B | 33.18B | 34.4B |
| Low Estimate | 8.6B | 7.55B | 32.9B | 32.69B |
| High Estimate | 9.2B | 8.72B | 33.54B | 35.88B |
| Year Ago Sales | 8.2B | 7.45B | 28.19B | 33.18B |
| Sales Growth (year/est) | 8.16% | 9.65% | 17.70% | 3.68% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMGN.BA | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
ABBV.BA AbbVie Inc.
20,775.00
-0.24%
PFE.BA Pfizer Inc.
7,980.00
-0.50%
MRK.BA Merck & Co., Inc.
23,675.00
+1.39%
0R34.IL Johnson & Johnson
143.00
+0.49%
PFE.DU Pfizer Inc
26.32
+1.08%
JNJ.F Johnson & Johnson
139.32
+0.66%
PFE.NE Pfizer Inc.
12.41
-1.12%
ABBV AbbVie Inc.
175.17
-1.87%
JNJ Johnson & Johnson
142.06
-0.15%
PFE Pfizer Inc.
26.72
-0.52%